CompletedNCT05470465
How antidepressants and oxycodone together affect breathing
About this title
Read the official source — NCT05470465Medication studyAges 18–50United StatesDepression
Understand this study
Who was this study for?
Listed age limits: 18 years to 50 years.
- Listed locations
- West BendSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: September 1, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 27
- Sponsor
- Food and Drug Administration (FDA)
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 18 Years to 50 Years
- Official registry ID
- NCT05470465
- Official title
Show the full official title
Clinical Study to Investigate the Effect of Administration of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
West Bend
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Food and Drug Administration (FDA).
Did this study involve medication?
Yes. The study involved medication, including Placebo and Oxycodone, Paroxetine and Oxycodone and Escitalopram and Oxycodone.
Who was this study for?
Listed age limits: 18 years to 50 years.
